1. Home
  2. VERA vs ZLAB Comparison

VERA vs ZLAB Comparison

Compare VERA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • ZLAB
  • Stock Information
  • Founded
  • VERA 2016
  • ZLAB 2013
  • Country
  • VERA United States
  • ZLAB China
  • Employees
  • VERA N/A
  • ZLAB N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • VERA Health Care
  • ZLAB Health Care
  • Exchange
  • VERA Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • VERA 2.5B
  • ZLAB 1.8B
  • IPO Year
  • VERA 2021
  • ZLAB 2017
  • Fundamental
  • Price
  • VERA $42.01
  • ZLAB $31.38
  • Analyst Decision
  • VERA Strong Buy
  • ZLAB Strong Buy
  • Analyst Count
  • VERA 9
  • ZLAB 4
  • Target Price
  • VERA $53.56
  • ZLAB $52.50
  • AVG Volume (30 Days)
  • VERA 683.6K
  • ZLAB 976.3K
  • Earning Date
  • VERA 11-07-2024
  • ZLAB 11-12-2024
  • Dividend Yield
  • VERA N/A
  • ZLAB N/A
  • EPS Growth
  • VERA N/A
  • ZLAB N/A
  • EPS
  • VERA N/A
  • ZLAB N/A
  • Revenue
  • VERA N/A
  • ZLAB $322,711,000.00
  • Revenue This Year
  • VERA N/A
  • ZLAB $48.34
  • Revenue Next Year
  • VERA N/A
  • ZLAB $47.12
  • P/E Ratio
  • VERA N/A
  • ZLAB N/A
  • Revenue Growth
  • VERA N/A
  • ZLAB 28.16
  • 52 Week Low
  • VERA $9.68
  • ZLAB $13.48
  • 52 Week High
  • VERA $50.78
  • ZLAB $36.60
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • ZLAB 70.41
  • Support Level
  • VERA $39.22
  • ZLAB $31.52
  • Resistance Level
  • VERA $50.00
  • ZLAB $36.60
  • Average True Range (ATR)
  • VERA 2.41
  • ZLAB 1.36
  • MACD
  • VERA 0.24
  • ZLAB 0.34
  • Stochastic Oscillator
  • VERA 28.53
  • ZLAB 58.60

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.

Share on Social Networks: